RAPP

Rapport Therapeutics
RAPP

Overview Fund Activity

35 hedge funds and large institutions have $593M invested in Rapport Therapeutics in 2024 Q2 according to their latest regulatory filings, with 35 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

Holders
35
Holders Change
+35
Holders Change %
–
% of All Funds
0.51%
Holding in Top 10
4
Holding in Top 10 Change
+4
Holding in Top 10 Change %
%
% of All Funds
0.06%
New
35
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Fidelity Investments
1
Fidelity Investments
Massachusetts
$116M
2
AVM
2
Arch Venture Management
Illinois
$86.7M
3
CAM
3
Cormorant Asset Management
Massachusetts
$68.4M
4
Capital International Investors
4
Capital International Investors
California
$60.5M
5
JJ
5
Johnson & Johnson
New Jersey
$58.1M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Shares
Change %
ACP
26
Acuta Capital Partners
California
$465K +$465K +20,000 New
Squarepoint
27
Squarepoint
New York
$380K +$380K +16,345 New
Two Sigma Investments
28
Two Sigma Investments
New York
$302K +$302K +13,000 New
Balyasny Asset Management
29
Balyasny Asset Management
Illinois
$233K +$233K +10,000 New
DKCM
30
Davidson Kempner Capital Management
New York
$229K +$229K +10,000 New
Barclays
31
Barclays
United Kingdom
$219K +$219K +9,400 New
SIM
32
Sandia Investment Management
Massachusetts
$116K +$116K +5,000 New
UBS Group
33
UBS Group
Switzerland
$72.7K +$72.7K +3,127 New
T
34
Tidemark
California
$25.3K +$25.3K +1,088 New
Royal Bank of Canada
35
Royal Bank of Canada
Ontario, Canada
$5K +$5K +225 New
1
2